Of the 164 trials, 34% (N = 56) assess disease-modifying biological agents, 41% (N = 68) test disease-modifying small molecule drugs, 10% (N = 17) evaluate cognitive enhancing agents, and 14% (N = 23) test drugs for the treatment of neuropsychiatric symptoms
The specific panels Integrative Peptides uses are not detailed on their website, though their FDA-compliant manufacturing claims suggest adherence to current Good Manufacturing Practices that require such testing
Rodent data suggest possible anti-inflammatory effects that could hypothetically support soft-tissue repair
Disclaimer: Vitamin injections are not intended to diagnose, treat, cure, or prevent any disease
The peptide's effects on hormonal systems, particularly growth hormone and cortisol, may have implications for certain conditions
M., de Visser, A